Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Belite Bio, Inc Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting October 14, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit October 08, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease September 10, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Participate in Three Upcoming Investor Conferences September 03, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer September 01, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update August 09, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference August 08, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results August 05, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Present at the JonesHealthcare Seaside Summit July 08, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan June 12, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference May 14, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update May 13, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference May 13, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results May 08, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant May 06, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting May 06, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting May 01, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Announces $25 Million Registered Direct Offering April 25, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan March 22, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website March 11, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 11, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results March 06, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Participate in the Leerink Partners Global Biopharma Conference March 04, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 07, 2024 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference November 30, 2023 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Participate in the BTIG Ophthalmology Day November 20, 2023 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results November 13, 2023 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results November 07, 2023 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting November 06, 2023 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting October 27, 2023 From Belite Bio, Inc Via GlobeNewswire Tickers BLTE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
